Gil I. Wolfe MD, FAAN
Gil I. Wolfe
MD, FAAN
Professor and Chairman; Irvin and Rosemary Smith Chair of Neurology; State University of New York Distinguished Professor; Chief of Service for Neurology
Jacobs School of Medicine & Biomedical Sciences
Specialty/Research Focus
Muscle disease; Muscular Dystrophy; Neurobiology; Neurology; Neuromuscular Disorders; Neuropathology; Peripheral neuropathy
Contact Information
Patient Care
Patient Care
This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.
View this physician on UBMDProfessional Summary:
I arrived in January 2012 to assume the role of Chair of the Department of Neurology at Univ. at Buffalo School of Medicine and Biomedical Sciences, the State University of New York. Prior to that time, I served as Professor of Neurology at University of Texas Southwestern Medical School in Dallas, Texas. In September 2004, I was named to the Dr. Bob and Jean Smith Foundation Distinguished Chair in Neuromuscular Disease Research. I also served as Co-Director of the Muscular Dystrophy Association Clinics and Director of the Myasthenia Gravis and Peripheral Neuropathy Clinics at UT Southwestern and was the Clinical Vice Chair for the department in Dallas.
My interests in neuromuscular medicine are wide but have mainly focused on myasthenia gravis and other disorders of neuromuscular transmission, as well as peripheral neuropathies. I am board certified both in neurology and neuromuscular medicine. I am also board certified in neurophysiology, and I perform electromyography and nerve conduction studies and monitor intraoperative evoked potentials for spine surgeries and other operative cases.
My main research interests include idiopathic and immune-mediated peripheral neuropathies and myasthenia gravis. My research has been sponsored by the National Institute of Health/NINDS, Muscular Dystrophy Association, Myasthenia Gravis Foundation of America, and Food and Drug Administration. I remain actively involved in the training of younger physicians, and have directed neuromuscular medicine and clinical neurophysiology fellowships and neurology residency training programs in the past.
Education and Training:
- MD, Medicine, University of Texas Southwestern Medical School (1989)
- BA, Biology, Princeton University, Cum Laude (1985)
Employment:
- Distinguished Professor, Neurology, University at Buffalo (2017-present)
- Chief of Service, Neurology, Kaleida Health (2012-present)
- Professor and Chairman, Neurology, Univ at Buffalo JSMBS (2012-present)
- SUNY Distinguished Professor, Neurology (2022-present)
- Professor, Neurology, University at Buffalo, State University of New York Jacobs School of Medicine & Biomedical Sciences (2012-present)
- Professor, Neurology, University of Texas Southwestern Medical School (1994–2011)
- Fellow, Neurology, University of Pennsylvania Medical Center Univ. of Pennsylvania (1993–1994)
- Resident, Neurology, University of Pennsylvania Medical Center Univ. of Pennsylvania (1990–1993)
- Intern, Internal Medicine, University of Pennsylvania Medical Center Univ. of Pennsylvania (1989–1990)
Awards and Honors:
- Dr. Morris B. Bender Annual Lectureship (2024)
- 10th Annual Mathilda Karel Spak Lecture (2022)
- SUNY Distinguished Professor (2022)
- Regional Top Doctor (2021)
- Clinical Research Acheivement Award Finalist (2020)
- Certificate of Recognition for Distinguished Service (2020)
- Reiner Lecture (2020)
- Carrell Krusen Neuromuscular Symposium Keynote Speaker (2020)
- Chancellor's Award for Excellence in Scholarship and Creative Activities (2018)
- Excellence in Teaching Pharmacy Students Award (2018)
- Univ. at Buffalo Distinguished Professor (2017)
- Warren Wisner Lecture in Myasthenia Gravis (2016)
- Doctor of the Year, Myasthenia Gravis Foundation of America (2015)
- Teacher of the Year Award (2014)
- Buffalo Spree Magazine Top Doctor (2014)
- Keynote Speaker (2013)
- Distinguished Lecturer (2013)
- Inaugural Keynote Address (2013)
- Guest Professor Univ. of Toronto (2013)
- Buffalo Spree Magazine Top Doctor (2013)
- Patricia A. Smith Distinguished Chair in Neuromuscular Disease Research (2012)
- US News and World Report (2012)
- Inaugural Mathilda Karel-Spak Lecturer (2011)
- Best Doctors in America (2011)
- Best Doctors in Dallas (2011)
- Texas Super Doctor (2011)
- Baldwin Myasthenia Gravis Lecturer (2008)
- American Academy of Neurology (2005)
- Marquis' Who's Who (2005)
- American Neurological Society (2004)
- Trephined Cranium Resident Teaching Award (2002)
- Lippincott Scholar (1987)
Research Expertise:
- Electromyography (EMG): Conduct electrophysiologic tests that assess the peripheral nervous system, including the neuromuscular junction and muscle.
- Intraoperative monitoring (IOM): Monitoring electrophysiologic properties in individual patients during surgery. It is most commonly applied for spinal surgeries, but is also used for resection of tumors affecting the brainstem and brain, itself; and can be applied in a variety of other ways as well.
- Neuromuscular clinical trials
- Neuromuscular disease
- Neuromuscular disorders: Evaluate and treat the diseases of the nervous system that impact motor neurons, peripheral nerve, the neuromuscular junction, and muscle. These include peripheral neuropathies, motor neuron disease, myasthenia gravis, and inflammatory and hereditary muscle disease.
- Neuromuscular outcome measures
Grants and Sponsored Research:
- January 2021–March 2024
Phase 3 randomized, double blind, placebo-controlled multicenter study to evaluate satralizumab in generalized myasthenia gravis (LUMINESCE).
Roche
Role: Co-Investigator - July 2018–June 2023
Network of Excellence in Neuroscience Clinical Trial: NeuroNEXT
NIH/NINDS
Role: Principal Investigator
$250,000 - January 2020–June 2021
International Treatment Guideline in Myasthenia Gravis
MG Foundation of America
Role: Co-Principal Investigator - January 2018–December 2019
PROMISE-MG: Prospective multicenter observational cohort study of comparative
PCORI
Role: Co-Investigator
$7,200 - March 2014–August 2015
International Myasthenia Gravis Treatment Guideline
MG Foundation of America
Role: Co-Principal Investigator
$25,000 - September 2005–July 2015
Thymectomy Trial in Non-thymomatous MG patients on prednisone
NIH/NINDS
Role: Principal Investigator
$995,672 - August 2012–July 2013
The Effectiveness of Prednisone for the Treatment of Ocular Myasthenia (EPITOME)FDA
FDA
Role: Co-Investigator
$13,000 - January 2010–December 2012
Genome-wide association study in myasthenia gravis
MG Foundation of America
Role: Co-Investigator
$50,000 - April 2014
Safety and efficacy of eculizimab in subjects with refractory myasthenia gravis
Alexion Pharmaceuticals
Role: Co-Investigator
$50,000
Journal Articles:
- Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BR, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Garcia Ramos GS, Verschuuren JJ, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Odenkirchen J, Sonett JR, Jaretzki A, Newsom-Davis J, Cutter GR. (2016) Randomized Trial of Thymectomy in Myasthenia Gravis. N Engl J Med (Aug), 375(6): 511-522.
- Kaminski HJ, Kusner LL, Cutter GR, Le Panse R, Wright CD, Perry Y, Wolfe GI. (2024) Does Surgical Removal of the Thymus Have Deleterious Consequences?. Neurology (Jun), 102(12): e209482.
- Rozen SM, Wolfe GI, Vernino S, Raskin P, Hynan LS, Wyne K, Fulmer R, Pandian G, Sharma SK, Mohanty AJ, Sanchez CV, Hembd A, Gorman A. (2024) Effect of Lower Extremity Nerve Decompression in Patients with Painful Diabetic Peripheral Neuropathy: The DNND Randomized, Observation Group- and Placebo Surgery-controlled Clinical Trial. Annals of surgery (Feb).
- Hamedani AG, McPherson TO, Aban I, Lee I, Kupersmith MJ, Wolfe GI, Kaminski HJ. (2023) Attitudes and Beliefs Toward Thymectomy in the Myasthenia Gravis Patient Registry. Journal of clinical neuromuscular disease (Jun), 24(4): 222-228.
- Sikorski P, Li Y, Cheema M, Wolfe GI, Kusner LL, Aban I, Kaminski HJ. (2023) Serum metabolomics of treatment response in myasthenia gravis. PloS one (Jan), 18(10): e0287654. doi:10.1371/journal.pone.0287654
- Nowak RJ, Coffey CS, Goldstein JM, Dimachkie MM, Benatar M, Kissel JT, Wolfe GI, Burns TM, Freimer ML, Nations S, Granit V, Smith AG, Richman DP, Ciafaloni E, Al-Lozi MT, Sams LA, Quan D, Ubogu E, Pearson B, Sharma A, Yankey JW, Uribe L, Shy M, Amato AA, Conwit R, O'Connor KC, Hafler DA, Cudkowicz ME, Barohn RJ, . (2022) Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study. Neurology (Jan), 98(4): e376-e389. doi:10.1212/WNL.0000000000013121
- Wolfe GI, Ward ES, de Haard H, Ulrichts P, Mozaffar T, Pasnoor M, Vidarsson G. (2021) IgG regulation through FcRn blocking: A novel mechanism for the treatment of myasthenia gravis. Journal of the neurological sciences (Nov), 430: 118074.
- Contreras JP, Salinas R, Vidal C, Hoffmeister L, Wolfe GI, Cea G. (2021) Validation of Spanish version of 15-item myasthenia gravis quality-of-life questionnaire. Acta neurologica Scandinavica (Nov), 144(5): 546-552.
- Lacomis D, Wolfe GI. (2021) What Is in the Neuromuscular Junction Literature?. Journal of clinical neuromuscular disease (Mar), 22(3): 147-154.
- Verma R, Wolfe GI, Kupersmith MJ. (2021) Ocular myasthenia gravis - How effective is low dose prednisone long term?. Journal of the neurological sciences (Jan), 420: 117274.
- Mantegazza R, Wolfe GI, Muppidi S, Wiendl H, Fujita KP, O'Brien FL, Booth HDE, Howard JF. (2020) Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during REGAIN and its open-label extension. Neurology (Nov).
- Narayanaswami P, Sanders DB, Wolfe G, Benatar M, Cea G, Evoli A, Gilhus NE, Illa I, Kuntz NL, Massey J, Melms A, Murai H, Nicolle M, Palace J, Richman D, Verschuuren J, Wolfe GI. (2020) International consensus guidance for management of myasthenia gravis: 2020 update. Neurology (Nov).
- Barohn RJ, Gajewski B, Pasnoor M, Brown A, Herbelin LL, Kimminau KS, Mudaranthakam DP, Jawdat O, Dimachkie MM, Iyadurai S, Stino A, Kissel J, Pascuzzi R, Brannagan T, Wicklund M, Ahmed A, Walk D, Smith G, Quan D, Heitzman D, Tobon A, Ladha S, Wolfe G, Pulley M, Hayat G, Li Y, Thaisetthawatkul P, Lewis R, Biliciler S, Sharma K, Salajegheh K, Trivedi J, Mallonee W, Burns T, Jacoby M, Bril V, Vu T, Ramchandren S, Bazant M, Austin S, Karam C, Hussain Y, Kutz C, Twydell P, Scelsa S, Kushlaf H, Wymer J, Hehir M, Kolb N, Ralph J, Barboi A, Verma N, Ahmed M, Memon A, Saperstein D, Lou JS, Swenson A, Cash T, Wolfe GI. (2020) Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial. JAMA Neurol (Aug).
- Howard JF, Nowak RJ, Wolfe GI, Freimer ML, Vu TH, Hinton JL, Benatar M, Duda PW, MacDougall JE, Farzaneh-Far R, Kaminski HJ, Barohn R, Dimachkie M, Pasnoor M, Farmakidis C, Liu T, Colgan S, Benatar MG, Bertorini T, Pillai R, Henegar R, Bromberg M, Gibson S, Janecki T, Freimer M, Elsheikh B, Matisak P, Genge A, Guidon A, David W, Habib AA, Mathew V, Mozaffar T, Hinton JL, Hewitt W, Barnett D, Sullivan P, Ho D, Howard JF, Traub RE, Chopra M, Kaminski HJ, Aly R, Bayat E, Abu-Rub M, Khan S, Lange D, Holzberg S, Khatri B, Lindman E, Olapo T, Sershon LM, Lisak RP, Bernitsas E, Jia K, Malik R, Lewis-Collins TD, Nicolle M, Nowak RJ, Sharma A, Roy B, Nye J, Pulley M, Berger A, Shabbir Y, Sachdev A, Patterson K, Siddiqi Z, Sivak M, Bratton J, Small G, Kohli A, Fetter M, Vu T, Lam L, Harvey B, Wolfe GI, Silvestri N, Patrick K, Zakalik K, Duda PW, MacDougall J, Farzaneh-Far R, Pontius A, Hoarty M. (2020) Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial. JAMA Neurol (May), 77(5): 582-592.
- Howard JF, Nowak RJ, Wolfe GI, Freimer ML, Vu TH, Hinton JL, Benatar M, Duda PW, MacDougall JE, Farzaneh-Far R, Kaminski HJ, Barohn R, Dimachkie M, Pasnoor M, Farmakidis C, Liu T, Colgan S, Benatar MG, Bertorini T, Pillai R, Henegar R, Bromberg M, Gibson S, Janecki T, Freimer M, Elsheikh B, Matisak P, Genge A, Guidon A, David W, Habib AA, Mathew V, Mozaffar T, Hinton JL, Hewitt W, Barnett D, Sullivan P, Ho D, Howard JF, Traub RE, Chopra M, Kaminski HJ, Aly R, Bayat E, Abu-Rub M, Khan S, Lange D, Holzberg S, Khatri B, Lindman E, Olapo T, Sershon LM, Lisak RP, Bernitsas E, Jia K, Malik R, Lewis-Collins TD, Nicolle M, Nowak RJ, Sharma A, Roy B, Nye J, Pulley M, Berger A, Shabbir Y, Sachdev A, Patterson K, Siddiqi Z, Sivak M, Bratton J, Small G, Kohli A, Fetter M, Vu T, Lam L, Harvey B, Wolfe GI, Silvestri N, Patrick K, Zakalik K, Duda PW, MacDougall J, Farzaneh-Far R, Pontius A, Hoarty M. (2020) Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial. JAMA Neurol (May), 77(5): 582-592.
- McPherson T, Aban I, Duda PW, Farzaneh-Far R, Wolfe GI, Kaminski HJ, Cutter G, Lee I. (2020) Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study. Muscle Nerve (May).
- Cudkowicz M, Chase MK, Coffey CS, Ecklund DJ, Thornell BJ, Lungu C, Mahoney K, Gutmann L, Shefner JM, Staley KJ, Bosch M, Foster E, Long JD, Bayman EO, Torner J, Yankey J, Peters R, Huff T, Conwit RA, Shinnar S, Patch D, Darras BT, Ellis A, Packer RJ, Marder KS, Chiriboga CA, Henchcliffe C, Moran JA, Nikolov B, Factor SA, Seeley C, Greenberg SM, Amato AA, DeGregorio S, Simuni T, Ward T, Kissel JT, Kolb SJ, Bartlett A, Quinn JF, Keith K, Levine SR, Gilles N, Coyle PK, Lamb J, Wolfe GI, Crumlish A, Mejico L, Iqbal MM, Bowen JD, Tongco C, Nabors LB, Bashir K, Benge M, McDonald CM, Henricson EK, Oskarsson B, Dobkin BH, Canamar C, Glauser TA, Woo D, Molloy A, Clark P, Vollmer TL, Stein AJ, Barohn RJ, Dimachkie MM, Le Pichon JB, Benatar MG, Steele J, Wechsler L, Clemens PR, Amity C, Holloway RG, Annis C, Goldberg MP, Andersen M, Iannaccone ST, Smith AG, Singleton JR, Doudova M, Haley EC, Quigg MS, Lowenhaupt S, Malow BA, Adkins K, Clifford DB, Teshome MA, Connolly N. (2020) Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials. JAMA Neurol (Mar).
- Lee I, Kuo HC, Aban IB, Cutter GR, McPherson T, Kaminski HJ, Sussman J, Ströbel P, Oger J, Cea G, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJG, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Minisman G, Sonett JR, Wolfe GI. (2020) Minimal manifestation status and prednisone withdrawal in the MGTX trial. Neurology (Jan), 95(6): 755-766.
- Allen JA, Gelinas DF, Freimer M, Runken MC, Wolfe GI. (2020) Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?. J Neurol Sci (Jan), 408: 116497-116497.
- Green JD, Barohn RJ, Bartoccion E, Benatar M, Blackmore D, Chaudhry V, Chopra M, Corse A, Dimachkie MM, Evoli A, Florence J, Freimer M, Howard JF, Jiwa T, Kaminski HJ, Kissel JT, Koopman WJ, Lipscomb B, Maestri M, Marino M, Massey JM, McVey A, Mezei MM, Muppidi S, Nicolle MW, Oger J, Pascuzzi RM, Pasnoor M, Pestronk A, Provenzano C, Ricciardi R, Richman DP, Rowin J, Sanders DB, Siddiqi Z, Soloway A, Wolfe GI, Wulf C, Drachman DB, Traynor BJ. (2020) Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America. BMJ Open (Jan), 10(9): 037909-037909.
- Mi W, Silvestri NJ, Wolfe GI. (2019) A Neurologist's Perspective on Thymectomy for Myasthenia Gravis: Current Perspective and Future Trials. Thorac Surg Clin (May), 29(2): 143-150.
- Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJGM, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Silvestri NJ, Conwit R, Sonett JR, Jaretzki A, Newsom-Davis J, Cutter GR. (2019) Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial. Lancet Neurol (Mar), 18(3): 259-268.
- Levine TD, Katz JS, Barohn R, Vaughan LJ, Dimachkie MM, Saperstein DS, Mozaffar T, Wolfe GI, Mayo MS, Badger GJ, Katzin L, Ritt E, Greer M, DiStefano J, Schmidt PM. (2018) Review process for IVIg treatment: Lessons learned from INSIGHTS neuropathy study. Neurol Clin Pract (Oct), 8(5): 429-436.
- Weis CA, Aban IB, Cutter G, Kaminski HJ, Scharff C, Grießmann BW, Deligianni M, Kayser K, Wolfe GI, Ströbel P, Marx A. (2018) Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution. PLoS One (Jun), 13(6): 0197435-0197435.
- Gwathmey KG, Sadjadi R, Horton WB, Conaway MR, Barnett-Tapia C, Bril V, Russell JW, Shaibani A, Mauermann ML, Hehir MK, Kolb N, Guptill J, Hobson-Webb L, Gable K, Raja S, Silvestri N, Wolfe GI, Smith AG, Malik R, Traub R, Joshi A, Elliott MP, Jones S, Burns TM. (2018) Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI. Neurology (Jun), 90(23): 2034-2041.
- Benatar M, Howard JF, Barohn R, Wolfe GI, Cutter G. (2018) Learning from the past: reflections on recently completed myasthenia gravis trials. Ann N Y Acad Sci (Jan), 1412(1): 5-13.
- Sanders DB, Wolfe GI, Narayanaswami P. (2018) Developing treatment guidelines for myasthenia gravis. Ann N Y Acad Sci (Jan), 1412(1): 95-101.
- Lacomis D, Silvestri NJ, Fine EJ, Wolfe GI. (2017) What's in the Literature?. J Clin Neuromuscul Dis (Mar), 18(3): 165-175.
- Silvestri NJ, Wolfe GI. (2017) Rituximab in Treatment-Refractory Myasthenia Gravis. JAMA Neurol (Jan), 74(1): 21-23.
- Sanders DB, Wolfe GI, Narayanaswami P. (2017) Author response: International consensus guidance for management of myasthenia gravis: Executive summary. Neurology (Jan), 88(5): 505-506.
- Burns TM, Sadjadi R, Utsugisawa K, Gwathmey KG, Joshi A, Jones S, Bril V, Barnett C, Guptill JT, Sanders DB, Hobson-Webb L, Juel VC, Massey J, Gable KL, Silvestri NJ, Wolfe G, Cutter G, Nagane Y, Murai H, Masuda M, Farrugia ME, Carmichael C, Birnbaum S, Hogrel JY, Nafissi S, Fatehi F, Ou C, Liu W, Conaway M. (2016) International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r. Muscle & nerve (Dec), 54(6): 1015-1022.
- Wolfe GI, Kaminski HJ, Sonnett JR, Aban IB, Kuo HC, Cutter GR. (2016) Randomized trial of thymectomy in myasthenia gravis. Journal of thoracic disease (Dec), 8(12): E1782-E1783. doi:10.21037/jtd.2016.12.80
- Silvestri NJ, Wolfe GI, Lacomis D. (2016) What's in the Literature?. Journal of clinical neuromuscular disease (Dec), 18(2): 108-117.
- Salins S, Teter B, Kavak K, Wolfe GI, Silvestri NJ. (2016) Low-Dose Medication and Long-Term Outcome in Myasthenia Gravis. J Clin Neuromuscul Dis (Dec), 18(2): 61-66.
- Silvestri NJ, Wolfe GI, Lacomis D, Bromberg MB. (2016) What's in the Literature?. Journal of clinical neuromuscular disease (Sep), 18(1): 47-59.
- Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, Kuntz N, Massey JM, Melms A, Murai H, Nicolle M, Palace J, Richman DP, Verschuuren J, Narayanaswami P. (2016) International consensus guidance for management of myasthenia gravis: Executive summary. Neurology (Jul), 87(4): 419-425.
- Silvestri NJ, Wolfe GI, Bromberg M, Lacomis D. (2016) What's in the Literature?. J Clin Neuromuscul Dis (Jun), 17(4): 227-238.
- Benatar M, Mcdermott MP, Sanders DB, Wolfe GI, Barohn RJ, Nowak RJ, Hehir M, Juel V, Katzberg H, Tawil R. (2016) Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial. Muscle Nerve (Mar), 53(3): 363-369.
- Lacomis D, Silvestri NJ, Wolfe GI, Bromberg MB. (2015) What's in the Literature?. J Clin Neuromuscul Dis (Sep), 17(1): 36-46.
- Benatar M, McDermott MP, Sanders DB, Wolfe GI, Barohn RJ, Nowak RJ, Hehir M, Juel V, Katzberg H, Tawil R. (2015) Efficacy of Prednisone for the Treatment of Ocular Myasthenia (EPITOME): A Randomized Controlled Trial. Muscle Nerve (Jul).
- Renton AE, Pliner HA, Provenzano C, Evoli A, Ricciardi R, Nalls MA, Marangi G, Abramzon Y, Arepalli S, Chong S, Hernandez DG, Johnson JO, Bartoccioni E, Scuderi F, Maestri M, Gibbs JR, Errichiello E, Chiò A, Restagno G, Sabatelli M, Macek M, Scholz SW, Corse A, Chaudhry V, Benatar M, Barohn RJ, McVey A, Pasnoor M, Dimachkie MM, Rowin J, Kissel J, Freimer M, Kaminski HJ, Sanders DB, Lipscomb B, Massey JM, Chopra M, Howard JF, Koopman WJ, Nicolle MW, Pascuzzi RM, Pestronk A, Wulf C, Florence J, Blackmore D, Soloway A, Siddiqi Z, Muppidi S, Wolfe G, Richman D, Mezei MM, Jiwa T, Oger J, Drachman DB, Traynor BJ. (2015) A genome-wide association study of myasthenia gravis. JAMA neurology (Apr), 72(4): 396-404. doi:10.1001/jamaneurol.2014.4103
- Kohli S, Farooq O, Jani RB, Wolfe GI. (2015) Cerebral paragonimiasis: an unusual manifestation of a rare parasitic infection. Pediatr Neurol (Mar), 52(3): 366-369.
- Singh K, Gupta R, Kamal H, Silvestri NJ, Wolfe GI. (2015) Posterior reversible encephalopathy syndrome secondary to blood transfusion. J Clin Neurosci (Mar), 22(3): 592-594.
- Wolfe GI, Rowland LP. (2014) Alfred Jaretzki III, MD. Muscle Nerve (Sep), 50(3): 311-312.
- Silvestri NJ, Wolfe GI. (2014) Treatment-refractory myasthenia gravis. J Clin Neuromuscul Dis (Jun), 15(4): 167-178.
- El-Dokla A, Silvestri NJ, Wolfe GI, Lacomis D. (2014) What‘s in the Literature?. J Clin Neuromuscul Dis (Mar), 15(3): 129-142.
- Silvestri NJ, Wolfe GI. (2013) Asymptomatic/pauci-symptomatic creatine kinase elevations (hyperckemia). Muscle Nerve (Jun), 47(6): 805-815.
- Trivedi JR, Silvestri NJ, Wolfe GI. (2013) Treatment of painful peripheral neuropathy. Neurol Clin (May), 31(2): 377-403.
- Pasnoor M, Nascimento OJ, Trivedi J, Wolfe GI, Nations S, Herbelin L, de Freitas MG, Quintanilha G, Khan S, Dimachkie M, Barohn R. (2013) North America and South America (NA-SA) neuropathy project. Int J Neurosci (Apr).
- Haley RW, Charuvastra E, Shell WE, Buhner DM, Marshall WW, Biggs MM, Hopkins SC, Wolfe GI, Vernino S. (2013) Cholinergic autonomic dysfunction in veterans with Gulf War illness: confirmation in a population-based sample. JAMA Neurol (Feb), 70(2): 191-200.
- Benatar M, Sanders DB, Wolfe GI, McDermott MP, Tawil R. (2012) Design of the Efficacy of Prednisone in the Treatment of Ocular Myasthenia (EPITOME) trial. Ann N Y Acad Sci (Dec), 1275(1): 17-22.
- Wolfe GI, Meriggioli MN, Ciafaloni E, Ruff RL. (2012) Introduction for myasthenia gravis and related disorders. Ann N Y Acad Sci (Dec), 1275(1): 0-0.
- Silvestri NJ, Wolfe GI. (2012) Asymptomatic/pauci-symptomatic creatine kinase elevations (hyperckemia). Muscle Nerve (Dec).
- Kaminski HJ, Kusner LL, Wolfe GI, Aban I, Minisman G, Conwit R, Cutter G. (2012) Biomarker development for myasthenia gravis. Ann N Y Acad Sci (Dec), 1275(1): 101-106.
- Silvestri NJ, Wolfe GI. (2012) Myasthenia gravis. Semin Neurol (Jul), 32(3): 215-226.
- Singer MA, Vernino SA, Wolfe GI. (2012) Idiopathic neuropathy: new paradigms, new promise. J Peripher Nerv Syst (May), 17 Su: 43-49.
- Cupler EJ, Berger KI, Leshner RT, Wolfe GI, Han JJ, Barohn RJ, Kissel JT. (2012) Consensus treatment recommendations for late-onset Pompe disease. Muscle Nerve (Mar), 45(3): 319-333.
- Minisman G, Bhanushali M, Conwit R, Wolfe GI, Aban I, Kaminski HJ, Cutter G. (2012) Implementing clinical trials on an international platform: Challenges and perspectives. J Neurol Sci (Feb), 313(1-2): 1-6.
- Muppidi S, Wolfe GI, Conaway M, Burns TM. (2011) MG-ADL: still a relevant outcome measure. Muscle Nerve (Nov), 44(5): 727-731.
- Cupler EJ, Berger KI, Leshner RT, Wolfe GI, Han JJ, Barohn RJ, Kissel JT. (2011) Consensus treatment recommendations for late-onset pompe disease. Muscle Nerve (Oct).
- Burns TM, Grouse CK, Wolfe GI, Conaway MR, Sanders DB. (2011) The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis. Muscle Nerve (Jan), 43(1): 14-18.
- Sadeghian H, Wolfe GI. (2010) Therapy update in nerve, neuromuscular junction and myopathic disorders. Curr Opin Neurol (Oct), 23(5): 496-501.
- Muppidi S, Saperstein DS, Shaibani A, Nations SP, Vernino S, Wolfe GI. (2010) Isolated neck extensor myopathy: is it responsive to immunotherapy?. J Clin Neuromuscul Dis (Sep), 12(1): 26-29.
- Pasnoor M, Wolfe GI, Nations S, Trivedi J, Barohn RJ, Herbelin L, McVey A, Dimachkie M, Kissel J, Walsh R, Amato A, Mozaffar T, Hungs M, Chui L, Goldstein J, Novella S, Burns T, Phillips L, Claussen G, Young A, Bertorini T, Oh S. (2010) Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience. Muscle Nerve (Mar), 41(3): 370-374.
- Muppidi S, Wolfe GI. (2009) Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravis. Front Neurol Neurosci (Apr), 26: 109-119.
- Meyer DM, Herbert MA, Sobhani NC, Tavakolian P, Duncan A, Bruns M, Korngut K, Williams J, Prince SL, Huber L, Wolfe GI, Mack MJ. (2009) Comparative clinical outcomes of thymectomy for myasthenia gravis performed by extended transsternal and minimally invasive approaches. Ann Thorac Surg (Feb), 87(2): 385-390.
- Wolfe GI, Barohn RJ, Sanders DB, McDermott MP. (2008) Comparison of outcome measures from a trial of mycophenolate mofetil in myasthenia gravis. Muscle Nerve (Nov), 38(5): 1429-1433.
- Aban IB, Wolfe GI, Cutter GR, Kaminski HJ, Jaretzki A, Minisman G, Conwit R, Newsom-Davis J. (2008) The MGTX experience: challenges in planning and executing an international, multicenter clinical trial. J Neuroimmunol (Sep), 201-2: 80-84.
- Nations SP, Boyer PJ, Love LA, Burritt MF, Butz JA, Wolfe GI, Hynan LS, Reisch J, Trivedi JR. (2008) Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology (Aug), 71(9): 639-643.
- Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, Flanigan KM, Pestronk A, Tawil R, Wolfe GI, Eagle M, Florence JM, King WM, Pandya S, Straub V, Juneau P, Meyers K, Csimma C, Araujo T, Allen R, Parsons SA, Wozney JM, Lavallie ER, Mendell JR. (2008) A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol (May), 63(5): 561-571.
- Wolfe GI, Oh SJ. (2008) Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis. Ann N Y Acad Sci (Jan), 1132: 71-75.
- Singer MA, Lazaridis C, Nations SP, Wolfe GI. (2008) Reversible nitrous oxide-induced myeloneuropathy with pernicious anemia: case report and literature review. Muscle Nerve (Jan), 37(1): 125-129.
- Newsom-Davis J, Cutter G, Wolfe GI, Kaminski HJ, Jaretzki A, Minisman G, Aban I, Conwit R. (2008) Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone. Ann N Y Acad Sci (Jan), 1132: 344-347.
- Singer MA, Statland JM, Wolfe GI, Barohn RJ. (2007) Primary lateral sclerosis. Muscle Nerve (Mar), 35(3): 291-302.
- Vernino S, Wolfe GI. (2007) Antibody testing in peripheral neuropathies. Neurol Clin (Feb), 25(1): 29-46.
- Oh SJ, Hatanaka Y, Hemmi S, Young AM, Scheufele ML, Nations SP, Lu L, Claussen GC, Wolfe GI. (2006) Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis. Muscle Nerve (Apr), 33(4): 500-504.
- Sheth MN, Nations SP, Wolfe GI, Trivedi JR. (2005) Von hippel-lindau disease associated with thymoma and myasthenia gravis. J Clin Neuromuscul Dis (Dec), 7(2): 59-61.
- Oh SJ, LaGanke C, Powers R, Wolfe GI, Quinton RA, Burns DK. (2005) Multifocal motor sensory demyelinating neuropathy: inflammatory demyelinating polyradiculoneuropathy. Neurology (Nov), 65(10): 1639-1642.
- Hatanaka Y, Hemmi S, Morgan MB, Scheufele ML, Claussen GC, Wolfe GI, Oh SJ. (2005) Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG. Neurology (Nov), 65(9): 1508-1509.
- Singer MA, Kojan S, Barohn RJ, Herbelin L, Nations SP, Trivedi JR, Jackson CE, Burns DK, Boyer PJ, Wolfe GI. (2005) Primary Lateral Sclerosis: Clinical and Laboratory Features in 25 Patients. J Clin Neuromuscul Dis (Sep), 7(1): 1-9.
- Wolfe GI, Young PK, Nations SP, Burkhead WZ, McVey AL, Barohn RJ. (2005) Brachial plexopathy following thoracoscapular fusion in facioscapulohumeral muscular dystrophy. Neurology (Feb), 64(3): 572-573.
- Wolfe GI, Gross B. (2004) Treatment review and update for myasthenia gravis. J Clin Neuromuscul Dis (Dec), 6(2): 54-68.
- Haley RW, Vongpatanasin W, Wolfe GI, Bryan WW, Armitage R, Hoffmann RF, Petty F, Callahan TS, Charuvastra E, Shell WE, Marshall WW, Victor RG. (2004) Blunted circadian variation in autonomic regulation of sinus node function in veterans with Gulf War syndrome. Am J Med (Oct), 117(7): 469-478.
- Wolfe GI, Trivedi JR. (2004) Painful peripheral neuropathy and its nonsurgical treatment. Muscle Nerve (Jul), 30(1): 3-19.
- Torabi AM, Patel RK, Wolfe GI, Hughes CS, Mendelsohn DB, Trivedi JR. (2004) Transverse myelitis in systemic sclerosis. Arch Neurol (Jan), 61(1): 126-128.
- Saperstein DS, Wolfe GI, Gronseth GS, Nations SP, Herbelin LL, Bryan WW, Barohn RJ. (2003) Challenges in the identification of cobalamin-deficiency polyneuropathy. Arch Neurol (Sep), 60(9): 1296-1301.
- Wolfe GI, Nations SP, Burns DK, Herbelin LL, Barohn RJ. (2003) Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjogren's syndrome. Neurology (Sep), 61(6): 873-873.
- Wolfe GI, Nations SP, Burns DK, Herbelin LL, Barohn RJ. (2003) Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjögren's syndrome. Neurology (Sep), 61(6): 873-873.
- Wolfe GI, Kaminski HJ, Jaretzki A, Swan A, Newsom-Davis J. (2003) Development of a thymectomy trial in nonthymomatous myasthenia gravis patients receiving immunosuppressive therapy. Ann N Y Acad Sci (Sep), 998: 473-480.
- Trivedi JR, Wolfe GI, Nations SP, Burns DK, Bryan WW, Dewey RB. (2003) Adult polyglucosan body disease associated with lewy bodies and tremor. Arch Neurol (May), 60(5): 764-766.
- Weintraub MI, Wolfe GI, Barohn RA, Cole SP, Parry GJ, Hayat G, Cohen JA, Page JC, Bromberg MB, Schwartz SL. (2003) Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial. Arch Phys Med Rehabil (May), 84(5): 736-746.
- Wolfe GI, Hotz SE, Barohn RJ. (2002) Treatment of painful peripheral neuropathy. J Clin Neuromuscul Dis (Dec), 4(2): 50-59.
- Wolfe GI, Barohn RJ, Foster BM, Jackson CE, Kissel JT, Day JW, Thornton CA, Nations SP, Bryan WW, Amato AA, Freimer ML, Parry GJ. (2002) Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis. Muscle Nerve (Oct), 26(4): 549-552.
- Wolfe GI, Barohn RJ. (2002) Painful Peripheral Neuropathy. Curr Treat Options Neurol (May), 4(3): 177-188.
- Katz JS, Barohn RJ, Kojan S, Wolfe GI, Nations SP, Saperstein DS, Amato AA. (2002) Axonal multifocal motor neuropathy without conduction block or other features of demyelination. Neurology (Feb), 58(4): 615-620.
- Katz JS, Saperstein DS, Wolfe G, Nations SP, Alkhersam H, Amato AA, Barohn RJ. (2001) Cervicobrachial involvement in diabetic radiculoplexopathy. Muscle & nerve (Jun), 24(6): 794-8.
- Plaster NM, Tawil R, Tristani-Firouzi M, Canún S, Bendahhou S, Tsunoda A, Donaldson MR, Iannaccone ST, Brunt E, Barohn R, Clark J, Deymeer F, George AL, Fish FA, Hahn A, Nitu A, Ozdemir C, Serdaroglu P, Subramony SH, Wolfe G, Fu YH, Ptácek LJ. (2001) Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell (May), 105(4): 511-9.
- Wolfe GI, der Sluis RW, Barohn RJ. (2000) Post-radiation lower motor neuron syndrome. J Clin Neuromuscul Dis (Dec), 2(2): 116-116.
- Kaminski HJ, Santillan C, Wolfe GI. (2000) Autoantibody Testing in Neuromuscular Disorders, Part II: Neuromuscular Junction, Hyperexcitability, and Muscle Disorders. J Clin Neuromuscul Dis (Dec), 2(2): 96-105.
- Leis AA, Wolfe GI, der Sluis RW, Barohn RJ. (2000) Post-radiation lower motor neuron syndrome. Journal of clinical neuromuscular disease (Dec), 2(2): 116-8.
- Wolfe GL, Kaminski HJ. (2000) Autoantibody testing in neuromuscular disorders, part I: peripheral neuropathies. Journal of clinical neuromuscular disease (Dec), 2(2): 84-95.
- Wolfe GI, Brower RD, Burns DK. (2000) Perineurial cell hyperplasia in early-onset polyneuropathy with multiple cranial neuropathies. Neuromuscul Disord (Oct), 10(7): 503-506.
- van der Sluis RW, Wolfe GI, Nations SP, Bryan WW, Krampitz DE, Kissel JT, Barohn RJ. (2000) Post-radiation lower motor neuron syndrome. Journal of clinical neuromuscular disease (Sep), 2(1): 10-7.
- Chudnow RS, Wolfe GI, Sparagana SP, Delgado MR, Batchelor L, Roach ES. (2000) Abnormal sudomotor function in the hypomelanotic macules of tuberous sclerosis complex. J Child Neurol (Aug), 15(8): 529-532.
- Wolfe GI, Barohn RJ, Amato AA. (2000) Chronic Cryptogenic Sensory Polyneuropathy. Archives of neurology (May), 57(5): 759-760.
- Wolfe GI, Baker NS, Haller RG, Burns DK, Barohn RJ. (2000) McArdle's disease presenting with asymmetric, late-onset arm weakness. Muscle Nerve (Apr), 23(4): 641-645.
- Lindenbaum Y, Nations SP, Barobn RJ, Wolfe GI. (2000) Recurrent critical illness myopathy in an asthmatic patient treated with corticosteroids. J Clin Neuromuscul Dis (Mar), 1(3): 145-146.
- Katz JS, Wolfe GI, Andersson PB, Saperstein DS, Elliott JL, Nations SP, Bryan WW, Barohn RJ. (1999) Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder. Neurology (Sep), 53(5): 1071-1076.
- Wolfe GI, Baker NS, Amato AA, Jackson CE, Nations SP, Saperstein DS, Cha CH, Katz JS, Bryan WW, Barohn RJ. (1999) Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics. Arch Neurol (May), 56(5): 540-547.
- Saperstein DS, Amato AA, Wolfe GI, Katz JS, Nations SP, Jackson CE, Bryan WW, Burns DK, Barohn RJ. (1999) Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve (May), 22(5): 560-566.
- Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ. (1999) Myasthenia gravis activities of daily living profile. Neurology (Apr), 52(7): 1487-1489.
- Katz JS, Wolfe GI, Iannaccone S, Bryan WW, Barohn RJ. (1999) The exercise test in Andersen syndrome. Arch Neurol (Mar), 56(3): 352-356.
- Nations SP, Wolfe GI, Amato AA, Jackson CE, Bryan WW, Barohn RJ. (1999) Distal myasthenia gravis. Neurology (Feb), 52(3): 632-634.
- Amato AA, Kagan-Hallet K, Jackson CE, Lampkin S, Wolfe GI, Ferrante M, Bigio EH, Barohn RJ. (1998) The wide spectrum of myofibrillar myopathy suggests a multifactorial etiology and pathogenesis. Neurology (Dec), 51(6): 1646-1655.
- Krampitz DE, Wolfe GI, Fleckenstein JL, Barohn RJ. (1998) Charcot-Marie-Tooth disease type 1A presenting as calf hypertrophy and muscle cramps. Neurology (Nov), 51(5): 1508-1509.
- Wasay M, Wolfe GI, Herrold JM, Burns DK, Barohn RJ. (1998) Chloroquine myopathy and neuropathy with elevated CSF protein. Neurology (Oct), 51(4): 1226-1227.
- Jackson CE, Amato AA, Bryan WW, Wolfe GI, Sakhaee K, Barohn RJ. (1998) Primary hyperparathyroidism and ALS: is there a relation?. Neurology (Jun), 50(6): 1795-1799.
- Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan WW. (1998) Reliability testing of the quantitative myasthenia gravis score. Ann N Y Acad Sci (May), 841: 769-772.
- Katz JS, Wolfe GI, Bryan WW, Tintner R, Barohn RJ. (1998) Acetylcholine receptor antibodies in the Lambert-Eaton myasthenic syndrome. Neurology (Feb), 50(2): 470-475.
- Wolfe GI, Barohn RJ. (1998) Cryptogenic sensory and sensorimotor polyneuropathies. Semin Neurol (Jan), 18(1): 105-111.
- Wolfe GI, Burns DK, Krampitz D, Barohn RJ. (1997) Cylindrical spirals of myofilamentous origin associated with exertional cramps and rhabdomyolysis. Neuromuscul Disord (Dec), 7(8): 536-538.
- Wolfe GI, El-Feky WH, Katz JS, Bryan WW, Wians FH, Barohn RJ. (1997) Antibody panels in idiopathic polyneuropathy and motor neuron disease. Muscle Nerve (Oct), 20(10): 1275-1283.
- Katz JS, Wolfe GI, Bryan WW, Jackson CE, Amato AA, Barohn RJ. (1997) Electrophysiologic findings in multifocal motor neuropathy. Neurology (Mar), 48(3): 700-707.
- Haley RW, Hom J, Roland PS, Bryan WW, Van Ness PC, Bonte FJ, Devous MD, Mathews D, Fleckenstein JL, Wians FH, Wolfe GI, Kurt TL. (1997) Evaluation of neurologic function in Gulf War veterans. A blinded case-control study. JAMA (Jan), 277(3): 223-230.
- Amato AA, Gronseth GS, Jackson CE, Wolfe GI, Katz JS, Bryan WW, Barohn RJ. (1996) Inclusion body myositis: clinical and pathological boundaries. Ann Neurol (Oct), 40(4): 581-586.
- Katz JS, Wolfe GI, Burns DK, Bryan WW, Fleckenstein JL, Barohn RJ. (1996) Isolated neck extensor myopathy: a common cause of dropped head syndrome. Neurology (Apr), 46(4): 917-921.
- Wolfe GI, Galetta SL, Teener JW, Katz JS, Bird SJ. (1995) Site of autonomic dysfunction in a patient with Ross' syndrome and postganglionic Horner's syndrome. Neurology (Nov), 45(11): 2094-2096.
- Wolfe GI, Raps EC, Galetta SL, Siderowf AD, Brown MJ, Bird SJ. (1995) Systemic non-Hodgkin's lymphoma manifesting as neurogenic respiratory failure. Neurology (Mar), 45(3 Pt): 589-590.
- Wolfe GI, Galetta SL, Mollman JE. (1994) Spontaneous remission of papilledema and sixth nerve palsy in acute lymphoblastic leukemia. J Neuroophthalmol (Jun), 14(2): 91-94.
- Wolfe GI, Taylor CL, Flamm ES, Gray LG, Raps EC, Galetta SL. (1993) Ocular tilt reaction resulting from vestibuloacoustic nerve surgery. Neurosurgery (Mar), 32(3): 417-420.
- Wolfe GI, Ross ED. (1987) Sensory aprosodia with left hemiparesis from subcortical infarction. Right hemisphere analogue of sensory-type aphasia with right hemiparesis?. Arch Neurol (Jun), 44(6): 668-671.
Professional Memberships:
- NeuroNEXT NIH/NINDS Network; Co-Chair of Recruitment, Retention and Diversity Committee (2020–2022)
- New York State Neurological Society; President (2019–2021)
- Association of University Professors of Neurology; Councilor, Executive Committee (2014–present)
- Western ALS Study Group; Investigator (2013–present)
- GBS/CIDP Foundation International; Medical Advisory Board Member Center of Excellence (2012–present)
- American Neurological Association; Member (2004–present)
- Myasthenia Gravis Foundation of America; Member of MSAB (2001–present)
- Muscle Study Group; Site Investigator (2000–present)
- AANEM; member and committee chair (1993–present)
- American Academy of Neurology; Fellow (1991–present)
Presentations:
- "Myasthenia Gravis: The Evolving Therapeutic Landscape" Cleveland Clinic Dept. of Neurology Grand Rounds (2024)
- "Core Concepts in Neuropathic Pain Management: Safe and Appropriate Opioid Prescribing in Neurology" American Academy of Neurology Annual Meeting (2024)
- "Novel Strategies for Clinical Trial Recruitment and Participation: A Path Forward" MDA Clinical and Scientific Conference (2024)
- "Core Concepts in Neuropathic Pain Management: Safe and Appropriate Opioid Prescribing in Neurology" Annual Meeting Education Program, American Academy of Neurology (2023)
- "Myasthenia Gravis in 2022: A Year in Review" Rare Disease Connect in Neurology Annual Meeting (2022)
- "Myasthenia Gravis Pathogenesis: What is the Role of the Thymus" Rare Disease Connect in Neurology Annual Meeting (2022)
- "The Role of Neonatal Fc Receptor Blocking Therapeutics in the Management of Patients with Generalized Myasthenia Gravis" 6th Annual Meeting of the Illinois State Neurological Society (2022)
- "Evolving Autoantibodies and Treatment Landscape in Myasthenia Gravis: The 2020 Update of the Consensus Treatment Recommendations for MG" 17th International Congress on Neuromuscular Diseases (2022)
- "Myasthenia Gravis: The Evolving Therapeutic Landscape" International Academic Seminar on Progress in Myasthenia Gravis, Hebei Medical University (2022)
- "Myasthenia Gravis: The Evolving Therapeutic Landscape" 10th Annual Mathilda Karel Spak Lecture, Univ. of California Irvine Health Neuromuscular Colloquium (2022)
- "Core Concepts in Neuropathic Pain Management: Safe and Appropriate Opioid Prescribing in Neurology" Annual Meeting Education Program, American Academy of Neurology (2022)
- "Treatment Decisions for Disorders with Multiple Therapies: Myasthenia Gravis" Muscular Dystrophy Association Clinical and Scientific Conference (2022)
- "New Treatments in Myasthenia Gravis: When and Should I?" National Patient Conference, Myasthenia Gravis Foundation of America (2022)
- "Evolving Therapeutic Landscapes in the Management of Myasthenia Gravis" Philippine Neurological Association 43rd Annual Convention (2021)
- "Research and Clinical Trials Update in Myasthenia Gravis" Northeast Regional Conference, Myasthenia Gravis Foundation of America (2021)
- "Autoantibodies and the Evolving MG Treatment Landscape: The 2020 Update of the Consensus International Treatment Recommendations for MG" AANEM Annual Meeting (2021)
- "New Developments in Managing Myasthenia Gravis" 3rd Annual International Congress on the Future of Neurology (2021)
- "The 2020 Update of the Consensus International Treatment Recommendations for Myasthenia Gravis" Keynote address: 1st Chinese Summit on Innovative Medicine and Public Welfare in Myasthenia Gravis and Neurology (2021)
- "Therapeutic Landscape and Novel Therapies for Myasthenia Gravis" Advanced Practice Provider education series, American Association of Neuromuscular and Electrodiagnostic Medicine (2021)
- "Core Concepts in Pain Management" American Academy of Neurology Virtual Annual Meeting (2021)
- "Therapeutic Landscape and Novel Therapies for Myasthenia Gravis" Dept. of Neurology Grand Rounds, St. Louis University School of Medicine (2021)
- "Minimal Manifestation Status and Prednisone Withdrawal in the MGTX Trial" Clinical and Translational Science Institute Annual Forum, Univ. at Buffalo (2021)
- "Therapeutic Landscape and Novel Therapies for Myasthenia Gravis" Dept. of Neurology Grand Rounds, Penn State College of Medicine (2021)
- "MGTX: A Closer Look into Outcomes from the Thymectomy Trial in Myasthenia Gravis" Dept. of Medicine Grand Rounds, Oakland University William Beaumont School of Medicine (2021)
- "Therapeutic Landscape and Novel Therapies for Myasthenia Gravis" Neuroscience Lecture Series, MIND Clinic (2021)
- "Reiner Lecture: Therapeutic Landscape and Novel Therapies for Myasthenia Gravis" American Association of Neuromuscular and Electrodiagnostic Medicine Annual Scientific Meeting (2020)
- "Myasthenia Gravis: Updates in Research" Muscular Dystrophy Association Engage Myasthenia Gravis Virtual Symposium (2020)
- "Neuromuscular Junction Disorders: Thymectomy" 16th International Congress on Neuromuscular Diseases, Virtual Plenary Session, (2020)
- "COVID-19 and Neuromuscular Medicine" Mini Grand Rounds COVID-19 Series (2020)
- "Chronic Inflammatory Demyelinating Polyneuropathy: assessing the application of intravenous and subcutaneous immunoglobulin, featuring a patient perspective" Pharmacy Times continuing education program (2020)
- "Carrell-Krusen Keynote Lecture: Novel Therapies for Myasthenia Gravis" 42nd Annual Carrell Krusen Neuromuscular Symposium; Univ. of Texas Southwestern Medical Center (2020)
- "MGTX: A Closer Look into Outcomes from the Thymectomy Trial in Myasthenia Gravis" Grand Rounds; Univ. of Texas Southwestern Medical Center; Dept of Neurology and Neurotherapeutics (2020)
- "A Closer Look into Outcomes from the Thymectomy Trial in Myasthenia Gravis" Grand Rounds; Univ. of Maryland School of Medicine; Dept. of Neurology (2020)
- "MGTX: A Closer Look into Outcomes from the Thymectomy Trial in Myasthenia Gravis" Grand Rounds; Univ. of Washington Medical Center; Dept. of Neurology (2020)
- "Evolution of Pathogenic Players and Treatment in Myasthenia Gravis" 25th Neurology Time Conference; Peking Union Medical College (2019)
- "Neurology Update 1: Neuromuscular Disease" AAN Annual Meeting; American Academy of Neurology (2019)
- "Primer on Myasthenia Gravis" 25th Neurology Time Conference; Peking Union Medical College (2019)
- "Respiratory and Crisis Management in Myasthenia Gravis" 5th Neurorespiratory Conference; Weizmann Institute (2019)
- "Therapeutic Landscape and Novel Therapies for Myasthenia Gravis" Mini-symposium on Myasthenia Gravis; Tel Aviv University; Sackler Faculty of Medicine (2019)
- "Practical Implementation of New Therapies: Treatment Landscape in Myasthenia Gravis" 2019 MDA Clinical and Scientific Conference; Muscular Dystrophy Association (2019)
- "Intraoperative Neurophysiologic Monitoring" Grand Rounds; Stony Brook University Renaissance School of Medicine; Dept of Neurology (2019)
- "MGTX: A Closer Look at Data from the Randomized Trial of Thymectomy in Myasthenia Gravis" Neurosciences Update 2018; Univ. of Kansas Health System; Dept. of Neurology (2018)
- "Immunotherapeutic Developments in Myasthenia Gravis" Immunoglobulin National Society National Conference; IgNS (2018)
- "Neuropathic Pain Management in Clinical Practice" Medical Center Conference; Galilee Medical Center (2018)
- "MGTX: A Deeper Dive into Outcomes from the Thymectomy Trial in Non-thymomatous Myasthenia Gravis" Grand Rounds; Univ. of Pittsburgh School of Medicine; Dept of Neurology (2018)
- "Clinical Implications of Old and New Pathogenic Players in Myasthenia Gravis" NerveCon III (2018)
- "Neuropathic Pain Management in Clinical Practice" NerveConIII (2018)
- "Evolution of Monoclonal Ab Treatment Approaches in MG" 15th Intl Congress on Neuromuscular Diseases; ICNMD (2018)
- "Overview of Treatment Guidelines for Myasthenia Gravis" 15th Intl Congress on Neuromuscular Diseases; ICNMD (2018)
- "Randomized Controlled Trial of Thymectomy: A Deeper Dive" 15th Intl Congress on Neuromuscular Diseases; ICNMD (2018)
- "Myasthenia Gravis Today: Treatment Update and Future Directions" Immunotherapy for Neurologic Disorders 2018; University of Pennsylvania Health System & Penn; Dept. of Neurology (2018)
- "Treatment of Myasthenia Gravis: Update and Future Directions" Grand Rounds; Univ. of Virginia School of Medicine; Dept of Neurology (2017)
- "Management of Myasthenic Crisis" 54th Congreso Argentino de Neurologia; Congreso Argentino de Neurologia (2017)
- "Update in the Treatment of Myasthenia Gravis" 54th Congreso Argentino de Neurologia; Congreso Argentino de Neurologia (2017)
- "Treatment Approach in Painful Peripheral Neuropathy" 3rd Annual UT Southwestern Neurotherapeutics Update; Univ. of Texas Southwestern Medical Center; Dept. of Neurology and Neurotherapeutics (2017)
- "An International Consensus Guidance Statement for the Management of Myasthenia Gravis" 4th Ottawa International Conference on Neuromuscular Disease and Biology; Univ. of Ottawa (2017)
- "Myasthenia Gravis: Advances in Therapy" 4th Ottawa International Conference on Neuromuscular Disease and Biology; University of Ottawa (2017)
- "New Neuromuscular Therapies: Snapshot of Immunotherapeutic Developments" American Association of Neuromuscular and Electrodiagnostic Medicine Annual Meeting; AANEM (2017)
- "Comparing and Contrasting Treatment Strategies around the World" 13th International Conference on Myasthenia Gravis and Related Disorders; NYAS/MGFA; New York Academy of Sciences (2017)
- "MGTX: Primary and Secondary Outcome Measures" 13th Intl Conference on Myasthenia Gravis and Related Disorders; NYAS/MGFA (2017)
- "MGTX: Results of the Multinational Thymectomy Trial in Non-thymomatous Myasthenia Gravis" 2017 American Academy of Neurology Annual Meeting; American Academy of Neurology; Clinical Trials Plenary Session (2017)
- "Results from the Thymectomy Trial" MGFA National Conference; ; MG Foundation of America (2017)
- "Thymectomy in Non-Thymomatous Myasthenia Gravis: Results from MGTX, a Randomized, Controlled Trial" Grand Rounds; Univ. of California Irvine School of Medicine; Dept. of Neurology (2017)
- "The World Speaks: An International Treatment Recommendation for Myasthenia Gravis" Special Lecture; Meir Medical Center; Dept of Neurology (2017)
- "Thymectomy in Non-Thymomatous Myasthenia Gravis: Results from MGTX, a Randomized, Controlled Trial" Grand Rounds; Stanford University; Dept of Neurology and Neuroscience Grand Rounds (2017)
- "MGTX: Results from the Thymectomy Trial in Non-thymomatous Myasthenia Gravis" Grand Rounds; New York-Presbyterian/Weill Cornell Medical Center; Dept. of Neurology (2016)
- "Myasthenia Gravis: Antibody Revolution to Treatment Evolution" New York State Neurological Society Fall Conference; NYS Neurological Society (2016)
- "MGTX: Results from the Thymectomy Trial in Non-thymomatous Myasthenia Gravis" MSG Annual Meeting; Muscle Study Group; MSG (2016)
- "MGTX: Results of the Multinational Thymectomy Trial in Non-thymomatous Myasthenia Gravis" Annual Warren Wismer Lecture in Myasthenia Gravis; University of Alberta Faculty of Medicine and Dentistry; Grand Rounds, Dept of Neurology (2016)
- "An International Treatment Recommendation for Myasthenia Gravis" VIII Simposio Internacional de Neurologia; Universidad de los Andes (2016)
- "Pharmacological Treatment Update in Neuropathic Pain" VIII Simposio Internacional de Neurologia; Univeridad de los Andes (2016)
- "Results of the Thymectomy Trial in Myasthenia Gravis" International Congress of Neuromuscular Diseases; World Federation of Neurology (2016)
- "Treatment of Myasthenia Gravis: General Treatment Approaches" International Congress of Neuromuscular Diseases; World Federation of Neurology (2016)
- "The World Speaks: International Consensus Recommendations for Myasthenia Gravis Management" Grand Rounds; SUNY Downstate Medical Center; Dept of Neurology (2016)
- "Myasthenia Gravis: UnMuSKing a New Phenotype" Grand Rounds; Albany Medical College; Neuroscience Institute (2015)
- "Myasthenia Gravis: UnMuSKing a Phenotype" Grand Rounds; NYU Langone Medical Center; Dept of Neurology (2015)
- "The World Speaks: International Consensus Recommendations for Myasthenia Gravis Management" American Association of Neuromuscular and Electrodiagnostic Medicine Annual Meeting; AANEM (2015)
- "Management Dilemmas in Neuroimmunological Conditions: Thymectomy in MG" 2nd World Congress of Neurotherapeutics (2015)
- "Myasthenia Gravis: UnMuSKing a New Phenotype" Grand Rounds, Mt. Sinai Beth Israel Mirken Dept. of Neurology; Mt. Sinai Beth Israel Medical Campus; Dept. of Neurology (2015)
- "What's New in Treatment Strategies for Myasthenia Gravis?" Canadian Neurological Sciences Federation 50th Congress; Canadian Neurological Sciences Federation (2015)
- "What’s New in Treatment Strategies for Myasthenia Gravis?" Canadian Neurological Sciences Federation 50th Congress (2015)
- "What‘s New in Treatment Strategies for MG in the New Era" 56th Annual Meeting, Japanese Society of Neurology; Japanese Society of Neurology (2015)
- "Treatment of Neuropathic Pain" Neurology Update for the Primary Care Professional; Univ. at Buffalo SMBS/SUNY; Dept. fof Neurology (2015)
- "Myasthenia Gravis: UnMuSKing a New Phenotype" Grand Rounds, Univ. of Pennsylvania Perelman School of Medicine; Univ. at Pennsylvania Perelman School of Medicine; Dept. of Neurology (2015)
- "Myasthenia Gravis: UnMuSKing a New Phenotype" Grand Rounds, Indiana University School of Medicine; Indiana University School of Medicine; Dept. of Neurology (2014)
- "Myasthenia Gravis: UnMuSKing a New Phenotype" Neuromuscular Grand Rounds, Case Western Reserve School of Medicine; Case Western Reserve University School of Medicine; Neuromuscular Division (2014)
- "What‘s New in Managing Myasthenia Gravis" Grand Rounds, Case Western Reserve University School of Medicine; Case Western Reserve University School of Medicine; Dept. of Neurology (2014)
- "What‘s New in Managing Myasthenia Gravis" Annual Fall Symposium, NY State Neurological Society; NY State Neurological Society (2014)
- "Myasthenia Gravis: UnMuSKing a New Phenotype" Grand Rounds, LSU Health Sciences Center; LSU Health Sciences Center-Shreveport School of Medicine; Dept of Neurology (2014)
- "Treatment of Painful Peripheral Neuropathy" American Academy of Neurology Annual Meeting; AAN (2014)
- "What's New in Managing Adult Myasthenia Gravis" Muscular Dystrophy Association Clinical Conference; MDA (2014)
- "Research Update on Myasthenia Gravis and Status of the MGTX Trial" Dept of Neurology Conference, Tel Aviv Univ. Sackler School of Medicine; Ichilov Hospital, Tel Aviv Univ Sackler School of Medicine; Dept of Neurology (2013)
- "MGTX-the NIH-Funded Thymectomy Trial in Non-thymomatous MG" Second Annual Wright State University and Premier Health Neuroscience Institute Symposium; Wright State Univ. Boonshoft School of Medicine (2013)
- "Research Update in Myasthenia Gravis" Fourth Annual MG Patient Education Conference, Houston Methodist Neurological Institute; Houston Methodist Neurological Institute (2013)
- "Overcoming Hurdles of Developing and Performing Clinical Trials" Muscle Study Group Annual Meeting; Muscle Study Group (2013)
- "Myasthenia Gravis Research Update" First Annual MDA Muscle Summit, Penn State Hershey Medical Center; Penn State Hershey Medical Center (2013)
- "Myasthenia Gravis Research Update" MG Foundation of America National Conference; MGFA (2013)
- "Status of the MGTX Trial in Nonthymomatous MG Patients" International Workshop on the Thymus, Univ. of Padua; Univ. of Padua (2013)
- "Myasthenia Gravis: UnMuSKing a New Phenotype" University of Toronto Annual Neuromuscular Day; University of Toronto (2013)
- "Update on the Thymectomy Trial in Nonthymomatous MG" 12th International Conference on MG and Related Disorders; New York Academy of Science (2012)
- "Thymectomy trial in non-thymomatous MG patients receiving prednisone (MGTX)" Immune Globe International Conference of Nervous System Autoimmunity; Neuro Globe (2012)
- "Thymectomy in Immune MG" UC Irvine MDA ALS and Neuromuscular Inaugural California Neuromuscular Sympsium; UC Irvine; Neurology (2011)
- "Update for MG" Arizona Neurological Society CME Conference; Arizona Neurological Society (2009)
- "UnMuSKing a New Phenotype and the Thymectomy Trial" Japanese Society of Neurology; Japanese Society of Neurology; 50th Annual Meeting (2009)
- "Treatment update in MG and other disorders of the NMJ" Update in Neuromuscular Diseases, Oregon Health and Science University; Oregon Health and Science University (2009)
Service Activities:
- NIH/NINDS Special Emphasis Panel in Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases and Functional Neurological Disorders; Primary reviewer (2023)
- Special Emphasis Panel in Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases and Functional Neurological Disorders; NINDS/NIH Study Section (2023–present)
- Food & Drug Administration, Cellular, Tissue, Gene Therapy Advisory Committee; Special Government Employee (2021–present)
- Food & Drug Administration, Cellular, Tissue, Gene Therapy Advisory Committee, Special Government Employee; Member, Special Government Employee (2021–present)
- Recruitment, Retention and Diversity Cmte, NeuroNEXT NINDS/NIH clinical trial network; Co-Chair (2021–present)
- New York State Neurological Society; President (2018–2020)
- New York State Neurological Society; Vice President (2017–2018)
- Electromyography laboratory; Clinical Staff (2012–present)
- Intraoperative monitoring Monitoring of surgical cases at Buffalo General Medical Center; Program Coordinator (2012–2020)
- Neurophysiology laboratory EMG and intraoperative monitoring services; Clinical Staff (2012–present)
- NINDS; NINDS Myasthenia Gravis Common Data Elements Group;; Chair (2012–present)
- Neuromuscular Clinic Weekly clinic at BGMC; Clinical Staff (2012–present)
- FPMP Governing Board; Member (2012–present)
- Executive; Member (2012–present)
- Inpatient General Neurology Service Four weeks a year attending on service with residents; Teacher (2012–present)
- Medical Scientific Advisory Board; Chair (2011–present)
- Neuropathy Measures Workgroup; Member (2011–2012)
- NINDS; NINDS Neuromuscular Disease Common Data Elements Group;; Panel Member (2011–2012)
- Practice Issues Review Panel; Member (2010–2014)
- Myasthenia Gravis Foundation of America; Myasthenia Gravis Foundation of America;; Grant Reviewer (2009–present)
- Neuromuscular Medicine Board Committee; Member (2009–present)
- Neuromuscular Update Committee; Chair (2007–2010)
- Myasthenia Gravis Foundation of America; Myasthenia Gravis Foundation of America;; Chair (2007–2008)
- Department of Defense; Department of Defense;; Ad Hoc Reviewer (2003)